CALLISTO PHARMACEUTICALS INC Operating Income
CALLISTO PHARMACEUTICALS INC reported Operating Income of -$418.00 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2012-11-19
- CALLISTO PHARMACEUTICALS INC operating income (loss) for the quarter ending 2012-09-30 was -$418.00K.
- CALLISTO PHARMACEUTICALS INC operating income (loss) for the quarter ending 2012-06-30 was -$3.35M.
- CALLISTO PHARMACEUTICALS INC operating income (loss) for the quarter ending 2012-03-31 was -$7.29M.
- CALLISTO PHARMACEUTICALS INC operating income (loss) for the quarter ending 2011-12-31 was -$8.19M.
- CALLISTO PHARMACEUTICALS INC operating income (loss) for fiscal 2011 was -$20.93M.
- CALLISTO PHARMACEUTICALS INC operating income (loss) for fiscal 2010 was -$16.93M.
- CALLISTO PHARMACEUTICALS INC operating income (loss) for fiscal 2009 was -$8.53M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 181 month | Operating Income (Loss) 184 month | Operating Income (Loss) 187 month | Operating Income (Loss) 190 month | Operating Income (Loss) 193 month | Operating Income (Loss) 196 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | -$418.00K 10-Q · filed 2012-11-19 | -$3.77M derived: sum of 2 quarters · filed 2012-11-19 | -$11.06M 10-Q · filed 2012-11-19 | -$19.25M derived: sum of 4 quarters · filed 2012-11-19 | -$136.34M 10-Q · filed 2012-11-19 | |||||
| 2012-06-30 | -$3.35M 10-Q/A · filed 2012-08-28 | -$10.64M 10-Q/A · filed 2012-08-28 | -$18.84M derived: sum of 3 quarters · filed 2012-08-28 | -$24.01M derived: sum of 4 quarters · filed 2012-11-19 | -$135.92M 10-Q/A · filed 2012-08-28 | |||||
| 2012-03-31 | -$7.29M 10-Q · filed 2012-05-15 | -$15.49M derived: sum of 2 quarters · filed 2012-05-15 | -$20.66M derived: sum of 3 quarters · filed 2012-11-19 | -$24.89M derived: sum of 4 quarters · filed 2012-11-19 | -$132.57M 10-Q · filed 2012-05-15 | |||||
| 2011-12-31 | -$8.19M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$13.37M derived: sum of 2 quarters · filed 2012-11-19 | -$17.60M derived: sum of 3 quarters · filed 2012-11-19 | -$20.93M 10-K · filed 2012-03-30 | -$125.28M 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | -$5.17M 10-Q · filed 2012-11-19 | -$9.40M derived: sum of 2 quarters · filed 2012-11-19 | -$12.74M 10-Q · filed 2012-11-19 | -$17.43M derived: sum of 4 quarters · filed 2012-11-19 | -$117.08M 10-Q · filed 2011-11-14 | |||||
| 2011-06-30 | -$4.23M 10-Q/A · filed 2012-08-28 | -$7.56M 10-Q/A · filed 2012-08-28 | -$12.26M derived: sum of 3 quarters · filed 2012-08-28 | -$15.86M derived: sum of 4 quarters · filed 2012-08-28 | -$111.91M 10-Q · filed 2011-08-15 | |||||
| 2011-03-31 | -$3.33M 10-Q · filed 2012-05-15 | -$8.02M derived: sum of 2 quarters · filed 2012-05-15 | -$11.63M derived: sum of 3 quarters · filed 2012-05-15 | -$17.63M derived: sum of 4 quarters · filed 2012-05-15 | ||||||
| 2010-12-31 | -$4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$8.30M derived: sum of 2 quarters · filed 2012-03-30 | -$14.30M derived: sum of 3 quarters · filed 2012-03-30 | -$16.93M 10-K · filed 2012-03-30 | ||||||
| 2010-09-30 | -$3.60M 10-Q · filed 2011-11-14 | -$9.61M derived: sum of 2 quarters · filed 2011-11-14 | -$12.24M 10-Q · filed 2011-11-14 | |||||||
| 2010-06-30 | -$6.01M 10-Q · filed 2011-08-15 | -$8.64M 10-Q · filed 2011-08-15 | ||||||||
| 2009-12-31 | -$8.53M 10-K · filed 2012-03-30 |